oAlert.pl
WARNING: RECALLED PRODUCT
PL EN

Atofab

Out-of-specification results were found for atomoxetine content and non-uniform capsule mass in batches manufactured from the same bulk batches; risk assessment indicates possible reduced therapeutic efficacy. Potential effects: possible treatment failure and worsening of disease symptoms.

Download the app and stay informed

Get instant notifications about recalled products and protect your family.

Atofab
Risk Level
Medium
Manufacturer
G.L. Pharma GmbH z siedzibą w Austrii
Batch Number
F06874
EAN Code
09008732012231
Recall Date
09.08.2024
View official statement

Important Information

What You Should Know

Recommendations

Do not use Atofab capsules from batches E01580 and FQ6874/F06874. Check the batch number on the pack; if you have these batches, return them to the pharmacy and consult a doctor if in doubt.

Actions Taken

The Chief Pharmaceutical Inspector suspended the distribution of Atofab 25 mg and 40 mg batches E01580 and FQ6874/F06874 throughout the country and granted the decision immediate enforceability; the p...

Need Help?

If you feel unwell after consuming this product, contact your doctor or call the poison control center.

FAQ

Frequently Asked Questions

Is this product safe to consume?
No. This product has been recalled due to: Out-of-specification results were found for atomoxetine content and non-uniform capsule mass in batches manufactured from the same bulk batches; risk assessment indicates possible reduced therapeutic efficacy. Potential effects: possible treatment failure and worsening of disease symptoms.
What should I do if I already bought this?
Stop using the product immediately. Return it to the store for a full refund. If you consumed it and feel unwell, contact your doctor.
Which batches are affected?
Affected batch numbers: F06874

Related

Other Recalled Products